Résumé À partir d'une revue de la littérature, cet article définit les limites de délinéation pour
les organes critiques, puis les contraintes de dose sur ces derniers lorsque la radiothérapie …

Introduction Hematologic toxicity (HT), particularly leukopenia, is a common side-effect of
oncologic treatments for pelvic malignancies. Pelvic nodal radiotherapy (PNRT) has been …

Purpose With the results of several recently published clinical trials, this guideline informs on
the use of adjuvant radiation therapy (RT) and systemic therapy in the treatment of …

Purpose To evaluate the toxicity and clinical outcome in patients with locally advanced
cervical cancer (LACC) treated with whole pelvic conventional radiation therapy (WP-CRT) …

PURPOSE: Intensity modulated radiation therapy (IMRT), compared with conventional 4-
field treatment, can reduce the volume of bone marrow irradiated. Pelvic bone marrow …

PURPOSE: To determine factors predictive for hematologic toxicity (HT) associated with
concurrent chemoradiation for Stage II through IV cervical cancer. METHODS AND …

PURPOSE: To evaluate disease outcomes and toxicity in cervical cancer patients treated
with pelvic intensity-modulated radiation therapy (IMRT). METHODS AND MATERIALS: We …

PURPOSE: Given that proliferating hematopoietic stem cells are especially radiosensitive,
the bone marrow is a potential organ at risk, particularly with the use of concurrent …

PURPOSE: To test the hypothesis that radiation dose to 18F-fluorodeoxyglucose positron
emission tomography (18F-FDG-PET)-defined active bone marrow (BMACT) subregions is …

Objective Image guidance should be used for patients with cervical cancer treated with
definitive intensity-modulated radiation therapy (IMRT). In this study, we provided a pattern …